|
1
|
Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.
|
Lancet Neurol
|
2009
|
4.11
|
|
2
|
Varicella-zoster virus in the saliva of patients with herpes zoster.
|
J Infect Dis
|
2008
|
3.52
|
|
3
|
Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.
|
Arch Neurol
|
2011
|
2.82
|
|
4
|
Stress-induced subclinical reactivation of varicella zoster virus in astronauts.
|
J Med Virol
|
2004
|
2.51
|
|
5
|
Neurological disease produced by varicella zoster virus reactivation without rash.
|
Curr Top Microbiol Immunol
|
2010
|
2.17
|
|
6
|
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.
|
Neurol Clin
|
2008
|
1.99
|
|
7
|
Clinical and molecular pathogenesis of varicella virus infection.
|
Viral Immunol
|
2003
|
1.67
|
|
8
|
Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia.
|
J Virol
|
2009
|
1.63
|
|
9
|
Varicella-zoster virus transcriptome in latently infected human ganglia.
|
J Virol
|
2010
|
1.51
|
|
10
|
Herpesvirus infections of the nervous system.
|
Nat Clin Pract Neurol
|
2007
|
1.48
|
|
11
|
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.
|
J Neurol Sci
|
2010
|
1.38
|
|
12
|
Varicella-zoster virus infection of differentiated human neural stem cells.
|
J Virol
|
2011
|
1.34
|
|
13
|
VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy.
|
Neurology
|
2005
|
1.33
|
|
14
|
Herpes simplex virus-1 and varicella-zoster virus latency in ganglia.
|
J Neurovirol
|
2003
|
1.30
|
|
15
|
The protean manifestations of varicella-zoster virus vasculopathy.
|
J Neurovirol
|
2002
|
1.28
|
|
16
|
Recurrent varicella zoster virus myelopathy.
|
J Neurol Sci
|
2008
|
1.26
|
|
17
|
Varicella zoster virus infection of highly pure terminally differentiated human neurons.
|
J Neurovirol
|
2012
|
1.20
|
|
18
|
Persistence of varicella zoster virus DNA in saliva after herpes zoster.
|
J Infect Dis
|
2011
|
1.17
|
|
19
|
Rapid and sensitive detection of 68 unique varicella zoster virus gene transcripts in five multiplex reverse transcription-polymerase chain reactions.
|
J Virol Methods
|
2009
|
1.17
|
|
20
|
Differential gene expression in human cerebrovascular malformations.
|
Neurosurgery
|
2003
|
1.13
|
|
21
|
Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death.
|
J Virol
|
2012
|
1.12
|
|
22
|
Aberrant virion assembly and limited glycoprotein C production in varicella-zoster virus-infected neurons.
|
J Virol
|
2013
|
1.04
|
|
23
|
Comparison of varicella-zoster virus RNA sequences in human neurons and fibroblasts.
|
J Virol
|
2014
|
1.03
|
|
24
|
Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia.
|
J Virol
|
2006
|
1.02
|
|
25
|
Varicella-zoster virus human ganglionic latency: a current summary.
|
J Neurovirol
|
2010
|
1.01
|
|
26
|
Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis.
|
Ann Neurol
|
2009
|
1.01
|
|
27
|
The variegate neurological manifestations of varicella zoster virus infection.
|
Curr Neurol Neurosci Rep
|
2013
|
0.98
|
|
28
|
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization.
|
J Infect Dis
|
2011
|
0.96
|
|
29
|
Molecular characterization of varicella zoster virus in latently infected human ganglia: physical state and abundance of VZV DNA, Quantitation of viral transcripts and detection of VZV-specific proteins.
|
Curr Top Microbiol Immunol
|
2010
|
0.94
|
|
30
|
Varicella zoster virus (VZV)-human neuron interaction.
|
Viruses
|
2013
|
0.93
|
|
31
|
Varicella zoster virus latency.
|
Future Virol
|
2011
|
0.93
|
|
32
|
Synthesis and decay of varicella zoster virus transcripts.
|
J Neurovirol
|
2011
|
0.89
|
|
33
|
Varicella-zoster virus trigeminal ganglioneuritis without rash.
|
Neurology
|
2013
|
0.89
|
|
34
|
Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186.
|
J Virol
|
2009
|
0.88
|
|
35
|
Subclinical reactivation of varicella zoster virus in all stages of HIV infection.
|
J Neurol Sci
|
2011
|
0.88
|
|
36
|
Chronic active varicella zoster virus infection.
|
Neurology
|
2012
|
0.88
|
|
37
|
Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.
|
J Virol
|
2006
|
0.86
|
|
38
|
Array analysis of simian varicella virus gene transcription in productively infected cells in tissue culture.
|
J Virol
|
2005
|
0.85
|
|
39
|
Clinical and molecular aspects of varicella zoster virus infection.
|
Future Neurol
|
2009
|
0.84
|
|
40
|
Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection.
|
PLoS Pathog
|
2013
|
0.83
|
|
41
|
Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.
|
J Gen Virol
|
2010
|
0.83
|
|
42
|
Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years.
|
J Med Virol
|
2013
|
0.82
|
|
43
|
Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia.
|
J Neurovirol
|
2003
|
0.81
|
|
44
|
Rapid and sensitive detection of varicella zoster virus in saliva of patients with herpes zoster.
|
J Virol Methods
|
2013
|
0.81
|
|
45
|
Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein.
|
J Virol
|
2012
|
0.81
|
|
46
|
Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection.
|
J Virol
|
2012
|
0.81
|
|
47
|
Persistence of varicella zoster virus DNA in saliva after herpes zoster.
|
J Infect Dis
|
2012
|
0.80
|
|
48
|
In vitro antiviral activity of honey against varicella zoster virus (VZV): A translational medicine study for potential remedy for shingles.
|
Transl Biomed
|
2012
|
0.80
|
|
49
|
Human trigeminal ganglionic explants as a model to study alphaherpesvirus reactivation.
|
J Neurovirol
|
2012
|
0.80
|
|
50
|
Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63.
|
Hybridoma (Larchmt)
|
2008
|
0.79
|
|
51
|
Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture.
|
J Neurovirol
|
2011
|
0.78
|
|
52
|
GeXPS multiplex PCR analysis of the simian varicella virus transcriptome in productively infected cells in culture and acutely infected ganglia.
|
J Virol Methods
|
2013
|
0.76
|
|
53
|
2012 Colorado alphaherpesvirus latency symposium.
|
J Neurovirol
|
2012
|
0.76
|
|
54
|
Varicella-zoster virus open reading frame 48 encodes an active nuclease.
|
J Virol
|
2013
|
0.76
|
|
55
|
Prevention of shingles: safety and efficacy of live zoster vaccine.
|
Ther Clin Risk Manag
|
2007
|
0.75
|
|
56
|
Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness.
|
J Neurol Sci
|
2011
|
0.75
|